Anne Lachiewicz, MD, MPH
@anne-lachiewicz.bsky.social
University of North Carolina transplant and burn infectious diseases. PD ICH ID fellowship. Wife. Teenage kids and dog mom. Love working out and reading books with happy endings.
December 29, 2024 at 9:13 PM
Merry Christmas 🌲⭐
December 26, 2024 at 3:10 AM
Merry Christmas 🌲⭐
Recommended change in MenB-4C (Bexsero) dosing for new immunogenity data. 2-dose schedule now 0 and 6 months for age 16-23 and new 3-dose schedule (0, 1–2, and 6 months) for age 10+ high risk www.cdc.gov/mmwr/volumes...
New Dosing Interval and Schedule for the Bexsero...
This report describes CDC’s updated recommendations for the MenB-4C vaccine to align the dosing interval and schedule with the new FDA label.
www.cdc.gov
December 19, 2024 at 5:01 PM
Recommended change in MenB-4C (Bexsero) dosing for new immunogenity data. 2-dose schedule now 0 and 6 months for age 16-23 and new 3-dose schedule (0, 1–2, and 6 months) for age 10+ high risk www.cdc.gov/mmwr/volumes...